Treatment of Gastroesophageal Reflux Disease After Lung Transplant Using Radiofrequency Ablation to the Lower Esophageal Sphincter (Stretta Procedure)

• Published in: The American surgeon Vol. 88; no. 7; p. 1663
• Main Authors: Kolbeinsson, Hordur M, Lawson, Cameron, Banks-Venegoni, Amy, Girgis, Reda, Scheeres, David E
• Format: Journal Article
• Language: English
• Published: United States 01.07.2022
• Subjects: Catheter Ablation - methods; Esophageal Sphincter, Lower - surgery; Fundoplication - methods; Gastroesophageal Reflux - complications; Gastroesophageal Reflux - surgery; Humans; Lung Transplantation; Treatment Outcome; gastrointestinal; endoscopy; lungs
• ISSN: 1555-9823
• DOI: 10.1177/0003134821998678

Gastroesophageal reflux disease (GERD) is associated with chronic lung allograft dysfunction after lung transplant. Treating GERD after lung transplant has been shown to improve lung allograft function. This case series describes the efficacy of the Stretta procedure to control GERD after lung transplant at our institution. Eleven patients underwent the Stretta procedure at our institution for GERD after lung transplant during the years 2016-2017. Pre- and post-Stretta reflux parameters were gathered. Pulmonary function was followed up until subsequent fundoplication surgery, death, or end of study observation. Reflux on esophagram was noted in 9 patients before Stretta and 8 patients after Stretta. The median number of acid reflux events was 31.5 vs. 26 after Stretta ( = .95), and median percent time in reflux was 17.7% before vs. 14.5% after Stretta ( = .76). Median DeMeester score before Stretta was 65.5 (range: 33.2-169.8) vs. 42.5 (range: 19.2-109.8) after the procedure ( = .14). Median lower esophageal resting pressure was 20.7 mm Hg (n = 7) compared to 25.9 mm Hg (n = 9) on post-Stretta follow-up ( = .99). Median FEV % predicted was 84% (41-97%) before compared to 71% (23-108%) at 1 year after the procedure ( = .14). Seven patients required fundoplication surgery for continued reflux. All patients were on triple immunosuppression, most commonly prednisone, tacrolimus, and mycophenolate (n = 9). The Stretta procedure did not provide expected results at our institution after lung transplant surgery. Based on our limited series, we do not recommend routine use of the Stretta procedure for management of GERD in lung transplant patients.